LINX

Did you Know?

Medications, such as PPIs and H2 Blockers, are designed to control or suppress acid production in the stomach. They do not address the source of reflux, the weak LES, and, therefore, cannot prevent reflux.

Downloadable Literature for LINX

Please click on the links below for downloadable LINX® literature. (PDF download)

Please click on the links below for downloadable LINX™ literature. (PDF download)

Product Brochure - English

Produkt-Broschüre - German

Opuscolo del prodotto - Italian
Post-Operative Patient Care - English

Postoperative geduldige Sorgfalt - German

Cura paziente postoperatoria - Italian
LINX Technology Guide - English

LINX Technologie-Führer - German

Guida di tecnologia di LINX - Italian

These documents are intended for European audiences and use only. Torax's LINX Reflux Management System has received European CE Mark approval for treatment of Gastro-oesophageal Reflux Disease (GORD), also known as GERD, and is available for sale in Europe.

CAUTION - Torax's FENIX™ Continence Restoration System is an INVESTIGATIONAL DEVICE, LIMITED BY U.S. FEDERAL LAW TO INVESTIGATIONAL USE. Not available for sale in the United States.

The FENIX™ Continence Restoration System has received European CE Mark approval for treatment of Fecal Incontinence (FI) and is available for sale in Europe.
Torax® Medical, LINX® Reflux Management System and FENIX™ Continence Restoration System are trademarks of Torax®Medical, Inc.
© 2011 Torax® Medical, Inc. All rights reserved.

Your Location:

LINX

Did you Know?

Downloadable Literature for LINX

CAUTION - Torax's FENIX™ Continence Restoration System is an INVESTIGATIONAL DEVICE, LIMITED BY U.S. FEDERAL LAW TO INVESTIGATIONAL USE. Not available for sale in the United States.